Hoyer D, Martin G
Novartis Pharma Ltd, Basel, Switzerland.
Neuropharmacology. 1997 Apr-May;36(4-5):419-28. doi: 10.1016/s0028-3908(97)00036-1.
Molecular biology has dramatically advanced our knowledge and understanding of receptors for 5-hydroxytryptamine (5-HT). The existence of multiple 5-HT receptors defined using traditional pharmacological and biochemical approaches has now been amply confirmed, but gene products encoding putative "new" 5-HT receptors have also been discovered. In some cases, the absence of suitably selective agonists and antagonists has hampered determination of a physiological role for these gene products. This makes their classification as formally recognised receptors premature.
分子生物学极大地推进了我们对5-羟色胺(5-HT)受体的认识和理解。使用传统药理学和生化方法确定的多种5-HT受体的存在现已得到充分证实,但编码假定“新”5-HT受体的基因产物也已被发现。在某些情况下,缺乏合适的选择性激动剂和拮抗剂阻碍了对这些基因产物生理作用的确定。这使得将它们归类为正式认可的受体还为时过早。